Jim Simons Protalix Bio Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 955,900 shares of PLX stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

955,900

Previous 804,600 18.8%

Holding current value

$1.67 Million

Previous $941,000 3.61%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.9 - $1.17 $136,170 - $177,021	151,300 Added 18.8%	955,900 $975,000
Q2 2024 Aug 09, 2024	SELL	$1.1 - $1.32 $22,110 - $26,532	-20,100 Reduced 2.44%	804,600 $941,000
Q1 2024 May 13, 2024	BUY	$1.22 - $1.82 $194,102 - $289,562	159,100 Added 23.9%	824,700 $1.04 Million
Q4 2023 Feb 13, 2024	BUY	$1.34 - $1.85 $59,630 - $82,325	44,500 Added 7.16%	665,600 $1.19 Million
Q3 2023 Nov 14, 2023	SELL	$1.49 - $2.02 $56,918 - $77,164	-38,200 Reduced 5.79%	621,100 $1.03 Million
Q2 2023 Aug 11, 2023	SELL	$2.0 - $3.36 $1.1 Million - $1.85 Million	-550,450 Reduced 45.5%	659,300 $1.32 Million
Q1 2023 May 12, 2023	BUY	$1.37 - $2.16 $1.35 Million - $2.13 Million	985,147 Added 438.62%	1,209,750 $2.54 Million
Q4 2022 Feb 13, 2023	BUY	$1.0 - $1.37 $107,403 - $147,142	107,403 Added 91.64%	224,603 $308,000
Q3 2022 Nov 14, 2022	BUY	$1.03 - $1.24 $2,472 - $2,976	2,400 Added 2.09%	117,200 $122,000
Q2 2022 Aug 12, 2022	BUY	$1.02 - $1.56 $104,958 - $160,524	102,900 Added 864.71%	114,800 $125,000
Q1 2022 May 13, 2022	BUY	$0.81 - $1.17 $9,639 - $13,923	11,900 New	11,900 $13,000
Q3 2021 Nov 12, 2021	SELL	$1.31 - $1.87 $39,398 - $56,240	-30,075 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$1.86 - $6.22 $888,259 - $2.97 Million	-477,559 Reduced 94.08%	30,075 $57,000
Q1 2021 May 13, 2021	BUY	$3.58 - $6.45 $68,020 - $122,550	19,000 Added 3.89%	507,634 $2.26 Million
Q4 2020 Feb 10, 2021	SELL	$3.15 - $3.98 $5,355 - $6,766	-1,700 Reduced 0.35%	488,634 $1.77 Million
Q3 2020 Nov 13, 2020	SELL	$3.37 - $3.93 $135,137 - $157,593	-40,100 Reduced 7.56%	490,334 $1.9 Million
Q2 2020 Aug 13, 2020	BUY	$2.19 - $4.5 $116,070 - $238,500	53,000 Added 11.1%	530,434 $2.01 Million
Q1 2020 May 14, 2020	BUY	$2.1 - $4.61 $37,380 - $82,058	17,800 Added 3.87%	477,434 $1.12 Million
Q4 2019 Feb 13, 2020	BUY	$1.8 - $3.28 $827,341 - $1.51 Million	459,634 New	459,634 $1.51 Million

Others Institutions Holding PLX

# of Institutions

Shares Held

3.58M

Call Options Held

61.1K

Put Options Held

36.2K

View Full List

About Protalix BioTherapeutics, Inc.

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $87.1M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

More about PLX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account